Skip to main content
Andrew Carlsen, MD, Cardiology, Sewanee, TN

AndrewBertCarlsenMD

Cardiology Sewanee, TN

Physician

Dr. Carlsen is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Carlsen's full profile

Already have an account?

  • Office

    182 Appletreewick St
    Sewanee, TN 37375
    Phone+1 931-233-1728

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterInternship, Transitional Year, 1965 - 1966
  • McGill University Faculty of Medicine
    McGill University Faculty of MedicineClass of 1965

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 1979 - 2015
  • VA State Medical License
    VA State Medical License 2004 - 2012

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Press Mentions

  • AbbVie : Clinical Trial of Investigational Epcoritamab (DuoBody-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in the Lancet
    AbbVie : Clinical Trial of Investigational Epcoritamab (DuoBody-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin's Lymphoma (B-NHL) Published in the LancetSeptember 14th, 2021
  • Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin’s Lymphoma (B-NHL) Published in the Lancet
    Clinical Trial of Investigational Epcoritamab (DuoBody®-CD3xCD20) in Patients with Relapsed/Refractory B-cell Non-Hodgkin’s Lymphoma (B-NHL) Published in the LancetSeptember 9th, 2021
  • Genmab and Bolt Biotherapeutics Announce Oncology Research and Development Collaboration
    Genmab and Bolt Biotherapeutics Announce Oncology Research and Development CollaborationJune 2nd, 2021
  • Join now to see all

Professional Memberships